
SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …
Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

